Contact Aadel

Speaking Engagements

  

Over the last few decades, the marked advances in cancer genomics have enabled better understanding, diagnosis and treatment of patients. However, secrets remain hidden under the complexities of the genome and translation into clinical benefit remains slow.

28-29 September 2022
  

In the wake of new FDA guidance and exciting MRD partnership announcements between Grail & AstraZeneca, Amgen & Bristol Myers Squibb the liquid biopsy industry is experiencing a paradigm shift.

16-17 November 2022